IP Library Granted Patent US 9,080,933
Granted Patent B2
US 9,080,933 · App. 13/891,005 · Granted Jul 14, 2015

Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates

Inventors: Patrick S. Stayton (Seattle, WA); Jriuan Lai (Seattle, WA); Barrett J. Nehilla (Seattle, WA); Selvi Srinivasan (Seattle, WA)
Assignee: University of Washington through its Center for Commercialization
G01N1/34B01D21/0009B03C1/01B03C1/288B82Y25/00C12N15/1013C12Q1/6834G01N27/745G01N33/54333B03C2201/18B03C2201/26G01N2001/4038G01N2001/4088Y10T436/00Y10T436/25
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,080,933
App. No.
13/891,005
Granted
Jul 14, 2015
Kind
B2
Abstract

The present disclosure utilizes the aggregation of stimuli-responsive polymers to isolate a diagnostic target (e.g., an antigen) from a solution using magnetophoresis. Isolating the diagnostic target provides a route to identify the presence of the diagnostic target in the solution.

Claims (37)

1. A method of concentrating a target in a liquid, comprising applying a magnetic field to an aggregate in the liquid to provide a collected aggregate by magnetophoresis, wherein the aggregate comprises:

(a) a stimuli-responsive magnetic nanoparticle comprising a first stimuli-responsive polymer attached to a magnetic core, wherein the stimuli-responsive magnetic nanoparticle does not include a capture moiety; and

(b) a stimuli-responsive capture conjugate comprising a second stimuli-responsive polymer attached to a capture moiety, wherein the capture moiety is capable of binding to a target;

wherein the aggregate is formed through associative interaction between the first stimuli-responsive polymer and the second stimuli-responsive polymer.

2. The method of claim 1 , wherein the magnetic field does not induce magnetophoresis in a non-aggregated stimuli-responsive magnetic nanoparticle in the liquid.

3. The method of claim 1 further comprising a step of concentrating the aggregate in the liquid.

4. The method of claim 1 , wherein the first stimuli-responsive polymer and the second stimuli-responsive polymer are responsive to stimuli independently selected from the group consisting of temperature, pH, light, photo-irradiation, exposure to an electric field, ionic strength, and combinations thereof.

5. The method of claim 1 , wherein the stimuli-responsive capture conjugate further comprises a detector complex comprising a detector moiety and a second capture moiety, wherein the second capture moiety is capable of binding to the target.

6. The method of claim 1 , wherein the target is an indicator for a disease or condition.

7. The method of claim 1 , wherein the target is selected from the group consisting of an antibody, an antigen, a cell, a nucleic acid, an enzyme, a substrate for an enzyme, a protein, a lipid, a carbohydrate, or other biomarker.

8. The method of claim 1 further comprising a biological sample selected from the group consisting of blood, mucus, urine, tissue, sputum, saliva, feces, a nasal swab, and nasopharyngeal washes.

9. The method of claim 1 , wherein the magnetic core is a metal oxide.

10. The method of claim 1 further comprising a second stimuli-responsive capture conjugate comprising a third stimuli-responsive polymer attached to a third capture moiety, wherein the third capture moiety is capable of capturing a second target, wherein the second target is different than the target.

11. A stimuli-responsive reagent, comprising:

(a) a stimuli-responsive magnetic nanoparticle comprising a first stimuli-responsive polymer attached to a magnetic core, wherein the stimuli-responsive magnetic nanoparticle does not include a capture moiety; and

(b) a stimuli-responsive capture conjugate comprising a second stimuli-responsive polymer attached to a first capture moiety, wherein the first capture moiety is capable of binding to a target.

12. The stimuli-responsive reagent of claim 11 , wherein the first stimuli-responsive polymer and the second stimuli-responsive polymer are responsive to stimuli independently selected from the group consisting of temperature, pH, light, photo-irradiation, exposure to an electric field, ionic strength, and combinations thereof.

13. The stimuli-responsive reagent of claim 11 , wherein the stimuli-responsive reagent further comprises a detector complex comprising a detector moiety and a second capture moiety, wherein the second capture moiety is capable of binding to the target.

14. The stimuli-responsive reagent of claim 11 , wherein the target is an indicator for a disease or condition.

15. The stimuli-responsive reagent of claim 11 , wherein the target is selected from the group consisting of an antibody, an antigen, a cell, a nucleic acid, an enzyme, a substrate for an enzyme, a protein, a lipid, a carbohydrate, or other biomarker.

16. The stimuli-responsive reagent of claim 11 , wherein the magnetic core is a metal oxide.

17. The stimuli-responsive reagent of claim 11 further comprising a second stimuli-responsive capture conjugate comprising a third stimuli-responsive polymer attached to a third capture moiety, wherein the third capture moiety is capable of capturing a second target, wherein the second target is different than the target.

18. A method of capturing a target in a liquid, comprising:

(a) contacting a liquid to be tested for the presence of a target with a stimuli-responsive reagent for a pre-determined period of time sufficient to effect binding of the target, if present, to the stimuli-responsive reagent, wherein the stimuli-responsive reagent comprises:

(i) a stimuli-responsive magnetic nanoparticle comprising a first stimuli-responsive polymer attached to a magnetic core, wherein the stimuli-responsive magnetic nanoparticle does not include a capture moiety; and

(ii) a stimuli-responsive capture conjugate comprising a second stimuli-responsive polymer attached to a capture moiety, wherein the capture moiety is capable of binding to a target;

(b) applying an effective stimulus to provide an aggregate in the liquid formed through associative interaction between the first stimuli-responsive polymer and the second stimuli-responsive polymer, wherein the aggregate comprises the stimuli-responsive magnetic nanoparticle and the stimuli-responsive capture conjugate, and wherein the capture moiety is bound to the target when the target is present in the liquid;

(c) subjecting the aggregate to a magnetic field to magnetophorese the aggregate to a site within the liquid to provide a magnetophoresed aggregate in the liquid; and

(d) analyzing the magnetophoresed aggregate to determine if the target is present.

19. The method of claim 18 further comprising binding a detector complex to the target, said detector complex comprising a second capture moiety capable of binding to the target and a reporting moiety.

20. The method of claim 19 , wherein the step of analyzing the magnetophoresed aggregate comprises photoluminescence analysis.

21. The method of claim 1 , wherein the stimuli-responsive capture conjugate does not include a magnetic nanoparticle.

22. The method of claim 1 , wherein the stimuli-responsive magnetic nanoparticle consists of the first stimuli-responsive polymer attached to the magnetic core.

23. The stimuli-responsive reagent of claim 11 , wherein the stimuli-responsive capture conjugate does not include a magnetic nanoparticle.

24. The stimuli-responsive reagent of claim 11 , wherein the stimuli-responsive magnetic nanoparticle consists of the first stimuli-responsive polymer attached to the magnetic core.

25. The method of claim 18 , wherein the stimuli-responsive capture conjugate does not include a magnetic nanoparticle.

26. The method of claim 18 , wherein the stimuli-responsive magnetic nanoparticle consists of the first stimuli-responsive polymer attached to the magnetic core.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2015
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035508/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2013
From: STAYTON, PATRICK S.; LAI, JRIUAN; NEHILLA, BARRETT J.; SRINIVASAN, SELVI
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 030860/0876 →
Continuity (4)
Continuation PCTUS2011035256 · May 4, 2011
Continuation In Part 12942919 · Nov 9, 2010
Provisional Application 61259545 · Nov 9, 2009
Related Publication 20130295585A1 · Nov 7, 2013